medigraphic.com
ISSN 2078-7170 (Electronic)

2012, Number 4

<< Back Next >>

CorSalud 2012; 4 (4)

Treatment levels and hypertension control at the Turcios Lima polyclinic

Naranjo DAA, González AA, Rodríguez NYÁ, Aroche AR

Language: Spanish
References: 33
Page: 254-260
PDF size: 158.19 Kb.


ABSTRACT

Introduction and objective: Pharmacological control of hypertension is an essential component in the stra-tegy for the control of cardiovascular diseases. The purpose of this research was to determine the current control rate of hypertension in the population receiving care at the medical office Nº 18 belonging to Turcios Lima Polyclinic, in Pinar del Rio municipality. Method: A descriptive and cross-sectional study was performed, the population consisted of 1589 patients over 15 years old, and the sample of 504 patients who were selected by stratified probability sampling. Results: A hypertension prevalence of 21.2% was found, which was greater in males. A control rate of 45 per 100 patients receiving therapy was calculated and a control rate of 65.3% among those treated. 42.3% of the population has a moderate cardiovascular risk of suffering a cardiovascular event in the next 10 years. Conclusions: A control level of high blood pressure higher than what has been previously reported in population studies conducted in other countries was obtained. This disease is better controlled in female patients. As for the overall cardiovascular risk, the moderate category was prevalent followed by the low risk, without underestimating the population classified as high risk.


REFERENCES

  1. O’Donnell CJ, Elosua R. Factores de riesgo cardio-vascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol. 2008;61(3):299-310.

  2. Dawber TR, Meadors GF, Moore FEJ. Epidemiolo-gical approaches to heart disease: the Framingham Study, Nations Health. Am J Public Health.1951; 41(3):279-86.

  3. Keys A, Taylor HL, Blackburn HB, Brozek J, An-derson JT, Simonson E. Coronary heart disease among Minnesota business and professional men followed 15 years. Circulation. 1963;28:381-95.

  4. Alfonzo Guerra JP. Hipertensión arterial en la aten-ción primaria de salud. En: Estratificación y valora-ción del riesgo cardiovascular de la hipertensión. La Habana: Ciencias Médicas; 2010. p. 109-20.

  5. Grau M, Marrugat J. Funciones de riesgo en la prevención primaria de las enfermedades cardio-vasculares. Rev Esp Cardiol. 2008;61(4):404-16.

  6. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al. Major risk factors as ante-cedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290(7):891-7.

  7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.

  8. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28(19):2375-414.

  9. Expert Panel on Detection, Evaluation, and Treat-ment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cho-lesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III). JAMA. 2001;285(19):2486-97.

  10. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart Disease and Stroke Statistcs 2012 Update: A report from the American Heart Association. Circulation. 2012; 125(1):e2-e220.

  11. Corderoa A, Lekuonab I, Galvec E, Mazón P; Sec-ción de Hipertensión Arterial, Grupo de Trabajo Co-razón y Diabetes, Grupo de Trabajo Cardio-Renal, Sociedad Española de Cardiología, España. Nove-dades en hipertensión arterial y diabetes mellitus: temas de actualidad en cardiología 2011. Rev Esp Cardiol. 2012;65(Supl 1):12-23.

  12. Ministerio de Salud Pública; Dirección nacional de registros médicos y estadísticas de salud. Anuario estadístico de salud 2010. La Habana: MINSAP; 2010.

  13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289(19): 2560-72.

  14. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciani A, Luque M, De la Cruz-Troca JJ, et al. Hypertension magnitude and management in the el-derly population of Spain. J Hypertens. 2002;20(11): 2157-64.

  15. Vasan RS, Beiser A, Seshadri S, Larson MG, Kan-nel WB, D’Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287(8):1003-10.

  16. Cordero A, Bertomeu V, Mazón P, Fácila L, Berto-meu V, Cosín-Sales J, et al. Factores asociados a la falta de control de la hipertensión arterial en pacientes con y sin enfermedad cardiovascular. Rev Esp Cardiol. 2011;64(7):587-93.

  17. Orduñez P, Bernal JL, Pedraza D, Espinosa- Brito A, Silva LC, Cooper R. El control de la hipertensión arterial en un escenario de recursos limitados: La experiencia cubana. J Hyperten. 2006;24:845-9.

  18. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension manage-ment in England: results from the Health Survey for England 2006. Hypertension. 2009;53(3):480-6.

  19. Egan BM, Zhao Y, Axon RN. US trends in preva-lence, awareness, treatment, and control of hyper-tension, 1988-2008. JAMA. 2010;303(20):2043-50.

  20. Ordúñez P, Silva LC, Rodriguez MP, Robles S. Pre-valence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Pan Am J Public Health. 2001;10(4):226-31.

  21. Franch Nadal J, Álvarez Torices JC, Álvarez Guisa-sola F, Diego Domínguez F, Hernández Mejía R, Cueto Espinar A. Epidemiología de la diabetes mellitus en la provincia de León. Med Clin (Barc). 1992;98(16):607-11.

  22. Botas Cervero P, Delgado Álvarez E, Castaño Fernández G, Díaz de Greñu C, Prieto Santiago J, Díaz Cadorniga FJ. Prevalencia de diabetes melli-tus e intolerancia a la glucosa en población entre 30 y 75 años en Asturias, España. Rev Clin Esp. 2002; 202(8):421-7.

  23. Masia R, Sala J, Rohlfs I, Piulats R, Manresa JM, Marrugat J. Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudio REGICOR. Rev Esp Cardiol. 2004;57(3):261-4.

  24. Pineda Cuenca M, Custardoy Olavarrieta J, Andreu Ruiz MT, Ortín Arróniz JM, Cano Montoro JG, Me-dina Ferrer E, et al. Estudio de prevalencia de facto-res de riesgo cardiovascular en un área de salud. Aten Primaria. 2002;30:207-13.

  25. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-200.

  26. Obesity: preventing and managing the global epide-mic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.

  27. Martínez JA, JM Kearney, Kafatos A, Paquet S, Martinez-Gonzalez. MA. Variables independently associated with self-reported obesity in the Euro-pean Union. Public Health Nutr. 1999;2(1): 125-33.

  28. Cerecero P, Hernández B, Aguirre D, Valdés R, Huitrón G. Estilos de vida asociados al riesgo car-diovascular global en trabajadores universitarios del Estado de México. Salud Pública Mex. 2009;51(6): 465-73.

  29. Organización Mundial de la Salud. Prevención de las enfermedades cardiovasculares: guía de bolsillo para la estimación y el manejo del riesgo cardiovas-cular Ginebra: OMS; 2008.

  30. Dueñas Herrera A, Armas Rojas NB, de la Noval García R, Turcios Tristá SE, Milián Hernández A, Cabalé Vilariño MB. Riesgo cardiovascular total en los trabajadores del Hotel "Meliá Cohíba". Rev Cu-bana Endocrinol [Internet]. 2008 [citado 15 Mayo 2010];19(1):[aprox. 6 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-29532008000100003&script=sci_arttext

  31. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47(8 Suppl): C101-3.

  32. Cañón L, Díaz N, Cruces E, Nieto T, Garrote T, Bui-trago F. Capacidad predictiva, comparación y con-secuencias clínicas de las tablas de Framingham-Wilson y REGICOR en personas atendidas en un centro de salud de Badajoz. Rev Esp Salud Pública. 2007;81(4):353-64.

  33. Mendivil C, Sierra I, Pérez C. Valoración del riesgo cardiovascular global y prevalencia de dislipidemias según los criterios del NCEP-ATPIII en una pobla-ción adulta de Bogotá, Colombia. Clin Invest Arte-rioscl. 2004;16(3):99-107.




2020     |     www.medigraphic.com